SG Americas Securities, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,949
+97.9%
14,144
+86.1%
0.02%
+91.7%
Q4 2022$985
-100.0%
7,600
-85.1%
0.01%
-70.7%
Q2 2022$3,828,000
+126.1%
51,064
+135.7%
0.04%
+241.7%
Q1 2022$1,693,000
+504.6%
21,668
+614.6%
0.01%
+1100.0%
Q3 2021$280,000
-57.4%
3,032
-64.2%
0.00%
-66.7%
Q2 2021$658,000
-48.1%
8,466
-50.3%
0.00%
-57.1%
Q1 2021$1,268,000
-1.8%
17,018
+124.8%
0.01%0.0%
Q4 2020$1,291,000
-71.7%
7,570
-76.7%
0.01%
-75.9%
Q3 2020$4,560,000
+472.9%
32,471
+554.4%
0.03%
+314.3%
Q2 2020$796,000
-83.1%
4,962
-89.7%
0.01%
-84.1%
Q1 2020$4,721,000
+2494.0%
48,265
+1901.0%
0.04%
+4300.0%
Q3 2019$182,000
-18.4%
2,412
+64.2%
0.00%
-50.0%
Q2 2019$223,000
-66.1%
1,469
-73.3%
0.00%
-66.7%
Q1 2019$657,000
+21.7%
5,511
+11.3%
0.01%
+20.0%
Q4 2018$540,000
+123.1%
4,950
+230.2%
0.01%
+150.0%
Q3 2018$242,000
-25.5%
1,499
-65.8%
0.00%
-33.3%
Q1 2018$325,000
+140.7%
4,386
+80.2%
0.00%
+200.0%
Q4 2017$135,000
-64.1%
2,434
-70.7%
0.00%
-66.7%
Q3 2017$376,000
+170.5%
8,300
+76.4%
0.00%
+200.0%
Q1 2017$139,000
-85.0%
4,706
-86.1%
0.00%
-87.5%
Q4 2016$929,000
+114.5%
33,875
+379.9%
0.01%
+60.0%
Q3 2016$433,000
+34.5%
7,059
-29.7%
0.01%
+150.0%
Q3 2015$322,000
+117.6%
10,036
-2.1%
0.00%
+100.0%
Q4 2014$148,000
-83.7%
10,251
-46.7%
0.00%
-75.0%
Q3 2013$909,00019,2400.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders